Search research articles
Contact Us
Filters
Showing results (121-130 of 144) with videos related to
Page
of 15
Sort By:
Heart (British Cardiac Society)
|
June 28, 2017
Persistent psychological distress and mortality in patients with stable coronary artery disease
Ralph A H Stewart, David M Colquhoun, Simone L Marschner, et al.
The Medical Journal of Australia
|
August 6, 2013
Psychosocial risk factors for coronary heart disease
Nick Glozier, Geoffrey H Tofler, David M Colquhoun, et al.
Plos Neglected Tropical Diseases
|
September 16, 2015
Rheumatic Heart Disease-Attributable Mortality at Ages 5-69 Years in Fiji: A Five-Year, National, Population-Based Record-Linkage Cohort Study
Tom Parks, Joseph Kado, Anne E Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 10, 2025
Repurposing a drug to punish carbapenem-resistant <i>Acinetobacter baumannii</i>
Jennifer M Colquhoun, Carter U Brzezinski, Andrew Ji, et al.
The Medical Journal of Australia
|
March 14, 2003
"Stress" and coronary heart disease: psychosocial risk factors
Stephen J Bunker, David M Colquhoun, Murray D Esler, et al.
Chemical Science
|
May 22, 2018
Elements of fractal geometry in the <sup>1</sup>H NMR spectrum of a copolymer intercalation-complex: identification of the underlying Cantor set
John S Shaw, Rajendran Vaiyapuri, Matthew P Parker, et al.
The New England Journal of Medicine
|
August 3, 2000
Pravastatin therapy and the risk of stroke
H D White, R J Simes, N E Anderson, et al.
Plos One
|
September 7, 2021
SARS-CoV-2 infections among Australian passengers on the Diamond Princess cruise ship: A retrospective cohort study
Liz J Walker, Tudor A Codreanu, Paul K Armstrong, et al.
Journal of the American Heart Association
|
October 25, 2013
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study
Harvey D White, John Simes, Ralph A H Stewart, et al.
International Journal of Cardiology
|
August 31, 2015
Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study
Andrew M Tonkin, Stefan Blankenberg, Adrienne Kirby, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 144) with videos related to
Sort By:
Page
of 15
Heart (British Cardiac Society)
|
June 28, 2017
Persistent psychological distress and mortality in patients with stable coronary artery disease
Ralph A H Stewart, David M Colquhoun, Simone L Marschner, et al.
The Medical Journal of Australia
|
August 6, 2013
Psychosocial risk factors for coronary heart disease
Nick Glozier, Geoffrey H Tofler, David M Colquhoun, et al.
Plos Neglected Tropical Diseases
|
September 16, 2015
Rheumatic Heart Disease-Attributable Mortality at Ages 5-69 Years in Fiji: A Five-Year, National, Population-Based Record-Linkage Cohort Study
Tom Parks, Joseph Kado, Anne E Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 10, 2025
Repurposing a drug to punish carbapenem-resistant <i>Acinetobacter baumannii</i>
Jennifer M Colquhoun, Carter U Brzezinski, Andrew Ji, et al.
The Medical Journal of Australia
|
March 14, 2003
"Stress" and coronary heart disease: psychosocial risk factors
Stephen J Bunker, David M Colquhoun, Murray D Esler, et al.
Chemical Science
|
May 22, 2018
Elements of fractal geometry in the <sup>1</sup>H NMR spectrum of a copolymer intercalation-complex: identification of the underlying Cantor set
John S Shaw, Rajendran Vaiyapuri, Matthew P Parker, et al.
The New England Journal of Medicine
|
August 3, 2000
Pravastatin therapy and the risk of stroke
H D White, R J Simes, N E Anderson, et al.
Plos One
|
September 7, 2021
SARS-CoV-2 infections among Australian passengers on the Diamond Princess cruise ship: A retrospective cohort study
Liz J Walker, Tudor A Codreanu, Paul K Armstrong, et al.
Journal of the American Heart Association
|
October 25, 2013
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study
Harvey D White, John Simes, Ralph A H Stewart, et al.
International Journal of Cardiology
|
August 31, 2015
Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study
Andrew M Tonkin, Stefan Blankenberg, Adrienne Kirby, et al.
Page
of 15